Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2016-09-20

Clinical Trial Update: Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

View source ↗

Summary

A clinical trial update discusses the risk of acute liver failure in patients with type 2 diabetes exposed to oral antidiabetic medications, based on AstraZenec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED